Biohaven Pharmaceuticals
5 followers
‌
Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.
Industries
Headquarters
Employees
Links
Org chart
Vlad Coric
CEO & Chairman
Vlad Coric
Collapse
Warren Volles
General Counsel & Chief Legal Officer
George Clark
VP, Chief Accounting Officer
Robert Croop
Chief Development Officer, Neurology
Bruce D. Car
Chief Scientific Officer
Tova Gardin
Chief Translational Officer
Cliff Bechtold
President & GM, Biohaven Ireland, Chief Compliance Officer
Matthew Buten
Chief Financial Officer
Elyse Stock
Senior Scientific Advisor
St John Donnie McGrath
Chief of Corporate Strategy & Business Development
David Stock
VP, Biostatistics
Michael Bozik
President, Ion Channel Research & Development
Melissa Beiner
Director, R&D
Wes Kazmierski
Senior Director, Chemistry
Katy Mcgrath
Principal Scientist, In Vivo Science
David Weaver
SVP, Neuroscience & Pharmacology
Similar companies
GRAIL
27 followers
Exelixis
11 followers
Ultragenyx Pharmaceutical
9 followers
United Therapeutics
6 followers
KBI Biopharma
5 followers
Aimmune Therapeutics
5 followers
Sage Therapeutics
4 followers
Molecular Devices
2 followers
MannKind
2 followers
MiMedx Group
2 followers
Ginkgo Bioworks
14 followers
Discover companies